Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Urogen Pharma Ltd. (URGN)  
$13.49 0.38 (2.9%) as of 4:30 Fri 6/27


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 42,110,000
Market Cap: 568.06(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $3.93 - $17.92
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  556
Guru Rank Value     : 3.3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   roGen Pharma is a biopharmaceutical company focused on developing and commercializing solutions that treat urothelial and specialty cancers. Co.'s approved product Jelmyto® (mitomycin) for pyelocalyceal solution, and its investigational candidate, UGN-102 (mitomycin) for intravesical solution, are designed to ablate tumors by non-surgical means and to treat several forms of non-muscle invasive urothelial cancer, including low-grade upper tract urothelial cancer and low-grade intermediate risk non-muscle invasive bladder cancer, respectively. In addition, Co.'s immuno-uro-oncology pipeline includes UGN-301 (zalifrelimab), an anti-CTLA-4 antibody.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 5,162 17,092 19,472 57,989
Total Sell Value $38,044 $170,944 $202,075 $783,323
Total People Sold 1 2 2 2
Total Sell Transactions 1 3 5 12
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 169
  Page 1 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Schoenberg Mark Chief Medical Officer   •       •      –    2025-06-09 4 S $7.37 $38,044 D/D (5,162) 153,378 -92%     
   Schoenberg Mark Chief Medical Officer   •       •      –    2025-06-08 4 OE $0.00 $0 D/D 10,000 158,540     -
   Smith Jason Drew General Counsel   •       •      –    2025-01-31 4 S $11.14 $82,202 D/D (7,379) 32,514 34%     
   Smith Jason Drew General Counsel   •       •      –    2025-01-31 4 OE $0.00 $0 D/D 14,667 35,281     -
   Schoenberg Mark Chief Medical Officer   •       •      –    2025-01-31 4 S $11.14 $50,698 D/D (4,551) 148,540 34%     
   Schoenberg Mark Chief Medical Officer   •       •      –    2025-01-31 4 OE $0.00 $0 D/D 8,000 150,436     -
   Kim Dong Chief Financial Officer   •       •      –    2024-09-09 4 OE $0.00 $0 D/D 2,500 37,753     -
   Schoenberg Mark Chief Medical Officer   •       •      –    2024-09-09 4 S $13.08 $11,236 D/D (859) 145,091 23%     
   Schoenberg Mark Chief Medical Officer   •       •      –    2024-09-09 4 OE $0.00 $0 D/D 1,666 145,950     -
   Smith Jason Drew General Counsel   •       •      –    2024-09-09 4 S $13.08 $19,895 D/D (1,521) 25,226 23%     
   Smith Jason Drew General Counsel   •       •      –    2024-09-09 4 OE $0.00 $0 D/D 3,333 26,747     -
   Schoenberg Mark Chief Medical Officer   •       •      –    2024-06-10 4 S $13.08 $67,401 D/D (5,153) 144,284 0%     
   Schoenberg Mark Chief Medical Officer   •       •      –    2024-06-10 4 OE $0.00 $0 D/D 10,000 149,437     -
   Schoenberg Mark Chief Medical Officer   •       •      –    2024-03-18 4 S $14.05 $168,600 D/D (12,000) 139,437 -11%     
   Smith Jason Drew General Counsel   •       •      –    2024-02-01 4/A S $15.78 $78,790 D/D (4,993) 23,414     -
   Schoenberg Mark Chief Medical Officer   •       •      –    2024-02-01 4/A S $15.78 $59,790 D/D (3,789) 151,437     -
   Kim Dong Chief Financial Officer   •       •      –    2024-01-31 4/A OE $0.00 $0 D/D 3,333 35,253     -
   Smith Jason Drew General Counsel   •       •      –    2024-01-31 4 S $15.74 $78,590 D/D (4,993) 23,414 17%     
   Smith Jason Drew General Counsel   •       •      –    2024-01-31 4 OE $0.00 $0 D/D 10,000 26,742     -
   Schoenberg Mark Chief Medical Officer   •       •      –    2024-01-31 4 S $15.74 $59,639 D/D (3,789) 151,437 17%     
   Schoenberg Mark Chief Medical Officer   •       •      –    2024-01-31 4 OE $0.00 $0 D/D 6,666 153,331     -
   Kim Dong Chief Financial Officer   •       •      –    2024-01-31 4 OE $0.00 $0 D/D 3,333 26,585     -
   Smith Jason Drew General Counsel   •       •      –    2023-08-31 4 S $18.01 $68,438 D/D (3,800) 18,407 19%     
   Smith Jason Drew General Counsel   •       •      –    2023-08-31 4 OE $0.00 $0 D/D 8,334 22,207     -
   Cohen Fred E Director   •       •      –    2023-07-26 4 A $9.54 $661,494 I/I 69,339 69,339     -

  169 Records found
  1  2  3  4  5  6  7   
  Page 1 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed